These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Will ASCOT change the form of anti-hypertensive therapy? Bilous R Diabet Med; 2006 Jan; 23(1):13-4. PubMed ID: 16409559 [No Abstract] [Full Text] [Related]
5. Cardiovascular risk profile and use of statins at the age of 70 years: a comparison of two Finnish birth cohorts born 20 years apart. Upmeier E; Vire J; Korhonen MJ; Isoaho H; Lehtonen A; Arve S; Wuorela M; Viitanen M Age Ageing; 2016 Jan; 45(1):84-90. PubMed ID: 26764397 [TBL] [Abstract][Full Text] [Related]
7. [Primary prevention of cardiovascular diseases by lowering lipids]. Klose G Internist (Berl); 1997 Jun; 38(6):615-6. PubMed ID: 9265009 [No Abstract] [Full Text] [Related]
8. The evolution of antihypertensive therapy: current theoretical conditions and individualized treatment options. Weber MA Am J Med; 1992 Aug; 93(2A):1S-3S. PubMed ID: 1519632 [No Abstract] [Full Text] [Related]
9. Is treatment of hypertension with acetylcholine esterase inhibitors (ACEIs) superior to other antihypertensives in preventing significant cardiovascular events and death in patients with type 2 diabetes? McConaghy JR J Fam Pract; 2000 Nov; 49(11):980. PubMed ID: 11093559 [No Abstract] [Full Text] [Related]
10. Lipids and Cardiovascular Disease: Putting It All Together. Pownall HJ; Gotto AM Methodist Debakey Cardiovasc J; 2019; 15(1):5-8. PubMed ID: 31049143 [No Abstract] [Full Text] [Related]